% | $
Quotes you view appear here for quick access.

CryoLife Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • sbarochia sbarochia Feb 3, 2010 12:46 PM Flag

    An opinion based upon a bit of guess work

    Following are sales numbers from MSN money, now where do you see drop in sales in last 6-7 years??
    12/09 108.60
    12/08 104.15
    12/07 93.71
    12/06 81.12
    12/05 69.24
    12/04 62.31
    12/03 59.04
    12/02 76.97
    12/01 86.68
    12/00 76.48
    12/99 65.85

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • dlhild Feb 3, 2010 8:52 PM Flag

      Think about it a little. Let's use your numbers. Total sales were $104.1M and 108.6M for 2008 and 2009, respectively. That would be an increase of about $4.5M. Now subtract off $4.5M for the increase in HemoStase sales. That means the net sales growth of the primary product lines, tissue and BioGlue, were essentially flat. Since they don't seem to be able to grow their two main product lines, they would seem to have a bit of a problem. I don't care about anything before 2008. Now do you understand? They may desperately need Medafor in order to grow revenues. However, if they need Medafor that badly, they will need to "pony up", and a crappy $2/share stock vague proposal worth only about $0.25/share seems to be absurd. CRY would probably want lock-up periods too. Medafor and CRY aren't even close to an offer that should even be considered by the Medafor board. Medafor employees are out growing revenues while CRY is dreaming. Who would even want to be acquired by a company who has demonstrated an inability to grow their own revenues? All my opinion anyway.

      On 2/18/10 they will issue actual numbers for the 4th quarter and for 2009. We can update to actual numbers at that time. Right now your 2009 number has to be an estimate. I think the estimate is a tad low, and will come in closer to $110M. This would show some very slow revenue growth.

11.28-0.03(-0.27%)Jul 2 4:02 PMEDT